Medacta Group SA (LON:0A05)
149.40
-0.66 (-0.44%)
At close: Oct 24, 2025
Medacta Group Revenue
Medacta Group had revenue of 344.14M EUR in the half year ending June 30, 2025, with 34.88% growth. This brings the company's revenue in the last twelve months to 646.07M, up 18.70% year-over-year. In the year 2024, Medacta Group had annual revenue of 590.58M with 15.62% growth.
Revenue (ttm)
646.07M EUR
Revenue Growth
+18.70%
P/S Ratio
5.08
Revenue / Employee
338.79K EUR
Employees
1,907
Market Cap
2.81B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 590.58M | 79.80M | 15.62% |
| Dec 31, 2023 | 510.78M | 73.66M | 16.85% |
| Dec 31, 2022 | 437.12M | 74.00M | 20.38% |
| Dec 31, 2021 | 363.13M | 60.63M | 20.04% |
| Dec 31, 2020 | 302.49M | -8.13M | -2.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |